Substance / Medication

Esomeprazole magnesium dihydrate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis.
Zhuang Qianjun, Chen Songfeng, Zhou Xuyu et al. · Am J Gastroenterol · 2024
PMID: 38345252Meta-Analysis
Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive esophagitis: A systematic review with meta-analysis of randomized controlled trials.
Simadibrata Daniel Martin, Lesmana Elvira, Fass Ronnie · J Gastroenterol Hepatol · 2024
PMID: 38353152Meta-Analysis
Achalasia: laparoscopic Heller myotomy with fundoplication versus peroral endoscopic myotomy-a systematic review and meta-analysis.
Sobral Joana, Machado Miguel, Barbosa José Pedro et al. · Esophagus · 2024
PMID: 38775883Meta-AnalysisFull text (PMC)
Iatrogenic duodenal diverticulum perforation: a systematic review.
Boot Madison, Chew Kenneth, Archer Jack et al. · ANZ J Surg · 2023
PMID: 36881513Meta-Analysis
Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis.
Witarto Andro Pramana, Witarto Bendix Samarta, Pramudito Shidi Laras et al. · Sci Rep · 2023
PMID: 37709957Meta-AnalysisFull text (PMC)
East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer disease.
He Yunye, Koido Masaru, Sutoh Yoichi et al. · Nat Genet · 2023
PMID: 38036781Meta-AnalysisFull text (PMC)
Evidence-Based Guidelines for the Treatment ofInfection in Korea 2020.
Jung Hye-Kyung, Kang Seung Joo, Lee Yong Chan et al. · Gut Liver · 2021
PMID: 33468712Meta-AnalysisFull text (PMC)
Duodenal ulcer perforation: A systematic literature review and narrative description of surgical techniques used to treat large duodenal defects.
Clinch Darja, Damaskos Dimitrios, Di Marzo Fransesco et al. · J Trauma Acute Care Surg · 2021
PMID: 34254960Meta-Analysis
Laparoscopic Repair for Perforated Peptic Ulcer Disease Has Better Outcomes Than Open Repair.
Quah Gaik S, Eslick Guy D, Cox Michael R · J Gastrointest Surg · 2019
PMID: 30465190Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Esomeprazole magnesium dihydrate (substance)
SNOMED CT
725855001
UMLS CUI
C3883231

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.